Howard Fillit

10.3k total citations · 2 hit papers
124 papers, 4.2k citations indexed

About

Howard Fillit is a scholar working on Psychiatry and Mental health, Physiology and Economics and Econometrics. According to data from OpenAlex, Howard Fillit has authored 124 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Psychiatry and Mental health, 32 papers in Physiology and 25 papers in Economics and Econometrics. Recurrent topics in Howard Fillit's work include Dementia and Cognitive Impairment Research (42 papers), Alzheimer's disease research and treatments (27 papers) and Health Systems, Economic Evaluations, Quality of Life (24 papers). Howard Fillit is often cited by papers focused on Dementia and Cognitive Impairment Research (42 papers), Alzheimer's disease research and treatments (27 papers) and Health Systems, Economic Evaluations, Quality of Life (24 papers). Howard Fillit collaborates with scholars based in United States, Canada and United Kingdom. Howard Fillit's co-authors include Pei‐Jung Lin, Peter J. Neumann, Diana W. Shineman, Joshua T. Cohen, Patrick R. Hof, Daniel P. Perl, Constantin Bouras, David T. Nash, John B. Zabriskie and Robert N. Butler and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Howard Fillit

120 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

2020 208 citations Howard Fillit, Michael Grundman et al. profile →
Dementia Diagnosis Disparities by Race and Ethnicity

2021 127 citations Peter J. Neumann, Howard Fillit et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Howard Fillit United States	37	1.4k	1.3k	733	577	524	124	4.2k
Dorota Religa Sweden	35	1.4k 1.0×	1.6k 1.3×	603 0.8×	410 0.7×	453 0.9×	131	4.2k
Howard Fillit United States	33	1.2k 0.9×	909 0.7×	1.2k 1.6×	507 0.9×	454 0.9×	85	5.6k
H. Michael Arrighi United States	29	2.1k 1.5×	1.9k 1.5×	1.0k 1.4×	435 0.8×	715 1.4×	52	6.4k
A. J. Larner United Kingdom	33	984 0.7×	1.7k 1.4×	508 0.7×	291 0.5×	399 0.8×	331	4.3k
Elizabeth Rimmer United States	5	1.2k 0.9×	2.0k 1.6×	438 0.6×	762 1.3×	472 0.9×	9	4.2k
Eva von Strauss Sweden	36	1.3k 1.0×	2.3k 1.8×	416 0.6×	899 1.6×	484 0.9×	77	5.4k
Kjeld Andersen Denmark	35	1.5k 1.1×	2.5k 2.0×	447 0.6×	728 1.3×	636 1.2×	128	7.0k
Kenji Toba Japan	38	2.0k 1.4×	1.1k 0.9×	804 1.1×	541 0.9×	276 0.5×	184	6.3k
Hiroyuki Umegaki Japan	39	1.6k 1.1×	967 0.8×	905 1.2×	304 0.5×	599 1.1×	229	5.1k
Nicola Vanacore Italy	39	947 0.7×	1.9k 1.5×	772 1.1×	323 0.6×	487 0.9×	259	5.6k

Countries citing papers authored by Howard Fillit

Since Specialization

Citations

This map shows the geographic impact of Howard Fillit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Fillit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Fillit more than expected).

Fields of papers citing papers by Howard Fillit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Fillit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Fillit. The network helps show where Howard Fillit may publish in the future.

Co-authorship network of co-authors of Howard Fillit

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Fillit. A scholar is included among the top collaborators of Howard Fillit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Fillit. Howard Fillit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Angioni, Davide, Lefkos Middleton, Randall J. Bateman, et al.. (2025). Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force. The Journal of Prevention of Alzheimer s Disease. 12(6). 100163–100163. 2 indexed citations

Cummings, Jeffrey L., Aaron H. Burstein, & Howard Fillit. (2025). Alzheimer Combination Therapies: Overview and Scenarios. The Journal of Prevention of Alzheimer s Disease. 12(10). 100328–100328.

Matthews, Dawn, Aaron Ritter, Ronald G. Thomas, et al.. (2021). Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia. Alzheimer s & Dementia Translational Research & Clinical Interventions. 7(1). e12106–e12106. 32 indexed citations

Aigbogun, Myrlene Sanon, Martin Cloutier, Marjolaine Gauthier‐Loiselle, et al.. (2020). Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review. Journal of Alzheimer s Disease. 77(3). 1181–1194. 16 indexed citations

Coste, F, Lin Xie, Myrlene Sanon Aigbogun, et al.. (2017). A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients. Neurology and Therapy. 6(1). 131–144. 22 indexed citations

Carman, Aaron J., Penny A. Dacks, Rachel Lane, Diana W. Shineman, & Howard Fillit. (2014). Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease. The journal of nutrition health & aging. 18(4). 383–392. 50 indexed citations

Feldman, Howard, Magali Haas, Sam Gandy, et al.. (2014). Alzheimer's disease research and development: a call for a new research roadmap. Annals of the New York Academy of Sciences. 1313(1). 1–16. 30 indexed citations

Dacks, Penny A., Diana W. Shineman, & Howard Fillit. (2013). Current evidence for the clinical use of long-chain polyunsaturated N-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease. The journal of nutrition health & aging. 17(3). 240–251. 52 indexed citations

Fillit, Howard, Robert K. Hofbauer, Juliana Setyawan, et al.. (2010). Memantine Discontinuation and the Health Status of Nursing Home Residents With Alzheimer's Disease. Journal of the American Medical Directors Association. 11(9). 636–644.e1. 10 indexed citations

10.

Shineman, Diana W., Timothy A. Salthouse, Lenore J. Launer, et al.. (2010). Therapeutics for cognitive aging. Annals of the New York Academy of Sciences. 1191(s1). E1–15. 7 indexed citations

11.

Johnson, Karen, Karen L. Margolis, Mark A. Espeland, et al.. (2008). A Prospective Study of the Effect of Hypertension and Baseline Blood Pressure on Cognitive Decline and Dementia in Postmenopausal Women: The Women's Health Initiative Memory Study. Journal of the American Geriatrics Society. 56(8). 1449–1458. 50 indexed citations

12.

Shumaker, Sally A., Claudine Legault, Lewis H. Kuller, et al.. (2004). Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women: Women???s Health Initiative Memory Study. Obstetrical & Gynecological Survey. 59(10). 711–711. 26 indexed citations

13.

Fillit, Howard, et al.. (1998). Practical geriatric assessment. 4 indexed citations

14.

Fillit, Howard. (1994). Challenges for Acute Care Geriatric Inpatient Units Under the Present Medicare Prospective Payment System. Journal of the American Geriatrics Society. 42(5). 553–558. 10 indexed citations

15.

Fillit, Howard, S Shibata, Takeshi Sasaki, et al.. (1993). Autoantibodies to the Protein Core of Vascular Basement Membrane Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus. Autoimmunity. 14(3). 243–249. 25 indexed citations

16.

Buée, Luc, Wanhong Ding, John P. Anderson, et al.. (1993). Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Research. 627(2). 199–204. 52 indexed citations

17.

Fulop, George, et al.. (1993). Identification of Alcoholism and Depression in a Geriatric Medicine Outpatient Clinic. Journal of the American Geriatrics Society. 41(7). 737–741. 28 indexed citations

18.

Fillit, Howard & Robert G. Lahita. (1991). Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus Erythematosus. Autoimmunity. 9(2). 159–164. 22 indexed citations

19.

Fillit, Howard, Éva Kemény, Victoria N. Luine, Marc E. Weksler, & John B. Zabriskie. (1987). Antivascular Antibodies in the Sera of Patients With Senile Dementia of the Alzheimer's Type. Journal of Gerontology. 42(2). 180–184. 58 indexed citations

20.

Kefalides, Nicholas A., et al.. (1986). Antibodies to basement membrane collagen and to laminin are present in sera from patients with poststreptococcal glomerulonephritis.. The Journal of Experimental Medicine. 163(3). 588–602. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact